How's this for belt-tightening? The Wall Street Journal reports that GlaxoSmithKline has announced it will "no longer use corporate funds for political contributions as part of an effort to improve openness in its business," according to the article. The company donated more than $585,000 in the US this year. (The company adopted this same policy in Europe in 2001.) No word, though, on whether that money will be redirected to R&D.